The Case for an Annual Covid Jab; Robinhood's Risk
In this week's BI radio show featuring our analysts and their research, pharma analyst Sam Fazeli suggests booster effectiveness appears to fade, making annual Covid shots likely in coming years. Julie Chariell discusses how Robinhood's risk from a shift in demand. Jon Tyce shows how persistent inflation is aiding net interest income outlooks for European and U.S. banks. Drew Reading lays out the next growth path for U.S. home centers. Andrew Silverman says which sectors would be boosted by the penny's demise.
The BI radio show podcasts through Apple’s iTunes, Spotify and Luminary. It broadcasts on Saturdays and Sundays at noon on Bloomberg’s flagship station WBBR (1130 AM) in New York, 106.1 FM/1330 AM in Boston, 99.1 FM in Washington, 960 AM in the San Francisco area, channel 119 on SiriusXM, www.bloombergradio.com, and iPhone and Android mobile apps.
Bloomberg Intelligence, the research arm of Bloomberg L.P., provides in-depth analysis and data on more than 2,000 companies and 130 industries. On the Bloomberg terminal, run BI